Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Neoplasm Metastasis 3 Fallopian Tube Neoplasms 3 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Rectal Neoplasms 2 Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Uveal Melanoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neurofibrosarcoma 1 Multiple Myeloma 1 Melanoma 1 Lung Cancer - Malignant Pleural Mesothelioma 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hemangiosarcoma 1 Esophagogastric Cancer 1 Esophageal Neoplasms 1 Disorders of Sex Development 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

Carboplatin 156 Paclitaxel 154 Bevacizumab 96 Cyclophosphamide 61 Gemcitabine 46 olaparib 45 Cisplatin 45 Topotecan 44 niraparib 40 liposomal doxorubicin 40 pembrolizumab 38 Surveys and Questionnaires 33 Filgrastim 31 Hyperthermic Intraperitoneal Chemotherapy 29 Docetaxel 27 Taxes 25 Blood Specimen Collection 24 fludarabine 23 Drug Therapy 23 Cytoreduction Surgical Procedures 23 Peripheral Blood Stem Cell Transplantation 21 Etoposide 21 Doxorubicin 21 Magnetic Resonance Spectroscopy 20 durvalumab 17 Specimen Handling 17 Albumin-Bound Paclitaxel 17 Immunoglobulin G 15 Disulfides 15 Letrozole 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ovarian Neoplasms × STA 9090 × Clear all

NCT03783949 2025-06-11

EUDARIO

Universitaire Ziekenhuizen KU Leuven

Phase 2 Completed

122 enrolled 23 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡